Folate-grafted glycyl-glycine-melphalan conjugate self-assembled amphilphilc nanomicelles augmented drug delivery, cytotoxicity and cellular uptake in human ovarian cancer cells

References

• Chen, B., et al., 2017. Current multistage drug delivery systems based on the tumor microenvironment. Theranostics, 7 (3), 538–558.
   PubMed Web of Science ®Google Scholar
• Chithrani, B.D., Ghazani, A.A., and Chan, W.C., 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano letters, 6 (4), 662–668.
   PubMed Web of Science ®Google Scholar
• Chung, J.E., et al., 2014. Self-assembled micellar nanocomplexes comprising green tea catechinderivatives and protein drugs for cancer therapy. Nature nanotechnology, 9 (11), 907–912.
   PubMed Web of Science ®Google Scholar
• Davis-Perry, S., et al., 2003. Melphalan for the treatment of patients with recurrent epithelial ovarian cancer. American journal of clinical oncology, 26 (4), 429–433.
   PubMedGoogle Scholar
• Deng, L., et al., 2019. Hydrophobic IR780 loaded sericin nanomicelles for phototherapy with enhanced antitumor efficiency. International journal of pharmaceutics, 566, 549–556.
   PubMedGoogle Scholar
• Dixit, N., et al., 2015. Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles. Biomedicine and pharmacotherapy, 69, 1–10.
   PubMed Web of Science ®Google Scholar
• Esma, F., et al., 2017. Melphalan hydrochloride for the treatment of multiple myeloma. Expert opinion on pharmacotherapy, 18 (11), 1127–1136.
   PubMed Web of Science ®Google Scholar
• Frohlich, E., 2012. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. The international journal of nanomedicine, 7, 5577–5591.
   PubMed Web of Science ®Google Scholar
• Garg, M., et al., 2012. Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells. Anti-cancer drugs, 23 (8), 836–845.
   PubMedGoogle Scholar
• Gratton, S.E., et al., 2008. The effect of particle design on cellular internalization pathways. Proceedings of the national academy of sciences, 105 (33), 11613–11618.
   PubMed Web of Science ®Google Scholar
• Hanafy, N., El-Kemary, M., and Leporatti, S., 2018. Micelles structure development as a strategy to improve smart cancer therapy. Cancers, 10 (7), 238. pii:
   Web of Science ®Google Scholar
• Hashemian, A.R. and Mansoori, G.A., 2013. Cancer nanodiagnostics and nanotherapeutics through the folate-conjugated nanoparticles. Journal of bioanalysis and biomedicine, 5, 3.
   Google Scholar
• Hashemian, A.R., et al., 2009. Folate-conjugated gold nanoparticles (synthesis, characterization and design for cancer cells nanotechnology-based targeting). The journal of nanoscience and nanotechnology, 5, 25–34.
   Google Scholar
• Hossen, S., et al., 2019. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. Journal of advanced research, 15, 1–18.
   PubMed Web of Science ®Google Scholar
• Hu, X.F. and Xing, P.X., 2003. Discovery and validation of new molecular targets for ovarian cancer. Current opinion in molecular therapeutics, 5 (6), 625–630.
   PubMedGoogle Scholar
• Kader, A. and Liu, H., 1997. Interference of anthracycline derivatives with measurement of proteins with BCA. Clinical chemistry, 43 (11), 2201–2202.
   PubMedGoogle Scholar
• Kalaydina, R.V., et al., 2018. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International journal of nanomedicine, 13, 4727–4745.
   PubMed Web of Science ®Google Scholar
• Kaur, A., et al., 2018. Self-assembled nanomicelles of amphiphilic clotrimazole glycyl-glycine analogue augmented drug delivery, apoptosis and restrained melanoma tumour progression. Materials science and engineering: C, 89, 75–86.
   PubMed Web of Science ®Google Scholar
• Kaur, K., et al., 2015. Stealth lipid coated aquasomes bearing recombinant human interferon-α-2b offered prolonged release and enhanced cytotoxicity in ovarian cancer cells. Biomedicine and pharmacotherapy, 69, 267–276.
   PubMedGoogle Scholar
• Luo, J.W., et al., 2016. One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine. International journal of nanomedicine, 11, 1051–1065.
   PubMed Web of Science ®Google Scholar
• Madan, J., et al., 2014. Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy. Anti-cancer drugs, 25, 704–716.
   PubMed Web of Science ®Google Scholar
• Mandal, A., et al., 2017. Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery. Molecular pharmaceutics, 14 (6), 2056–2069.
   PubMed Web of Science ®Google Scholar
• Mansoori, G.A., Brandenburg, K.S., and Shakeri-Zadeh, A., 2010. A comparative study of two folate-conjugated gold nanoparticles for cancer nanotechnology applications. Cancers, 2 (4), 1911–1928.
   PubMedGoogle Scholar
• Metrics, P.X., 1966. Qualitative and quantitative tests for melphalan. The journal of pharmaceutical sciences, 55, 726–727.
   PubMedGoogle Scholar
• Moreau, P., Le Bonniec, M., and Harousseau, J.L., 1999. High-dose melphalan in patients with multiple myeloma. Bull cancer, 86 (3), 283–288.
   PubMedGoogle Scholar
• Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods, 65 (1–2), 55–63.
   PubMed Web of Science ®Google Scholar
• Mougenot, P., et al., 2006. Phase II study of melphalan as a single-agent infused over a 24-hour period with individual adapted dosing in patients with recurrent epithelial ovarian cancer. Oncology reports, 15, 237–241.
   PubMedGoogle Scholar
• Muhamad, N., Plengsuriyakarn, T., and Na-Bangchang, K., 2018. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. International journal of nanomedicine, 13, 3921–3935.
   PubMed Web of Science ®Google Scholar
• Narmani, A., et al., 2019. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems. Drug development research, 80 (4), 404–424.
   PubMed Web of Science ®Google Scholar
• Osher, D.J., et al., 2011. Melphalan as a treatment for BRCA-related ovarian carcinoma: can you teach an old drug new tricks? Journal of clinical pathology, 64 (10), 924–926.
   PubMedGoogle Scholar
• Piazzini, V., et al., 2019. Formulation of nanomicelles to improve the solubility and the oral absorption of silymarin. Molecules, 24 (9), 1688.
   PubMed Web of Science ®Google Scholar
• Pradeep, P., et al., 2017. Targeted nanotechnologies for cancer intervention: a patent review (2010–2016). Expert opinion on therapeutic patents, 27 (9), 1005–1019.
   PubMed Web of Science ®Google Scholar
• Puri, R., et al., 2016. Sigma-2 receptor ligand anchored telmisartan loaded nanostructured lipid particles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in prostate cancer cells. Drug development and industrial pharmacy, 42 (12), 2020–2030.
   PubMed Web of Science ®Google Scholar
• Qiu, Y., et al., 2010. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials, 31 (30), 7606–7619.
   PubMed Web of Science ®Google Scholar
• Ramzy, L., et al., 2017. Cancer nanotheranostics: a review of the role of conjugated ligands for overexpressed receptors. European journal of pharmaceutical sciences, 104, 273–292.
   PubMed Web of Science ®Google Scholar
• Rothbarth, J., et al., 2004. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo. Biochemical pharmacology, 67 (9), 1771–1778.
   PubMedGoogle Scholar
• Ruiz, C.C., Hierrezuelo, J.M., and Molina-Boliva, J.A., 2015. Analysis of the photophysical behavior and rotational-relaxation dynamics of coumarin 6 in nonionic micellar environments: the effect of temperature. Molecules, 20 (10), 19343–19360.
   PubMedGoogle Scholar
• Saini, J., et al., 2014. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells. Colloids and surfaces. B, biointerfaces, 118, 101–110.
   PubMed Web of Science ®Google Scholar
• Salatin, S., et al., 2017. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Research in pharmaceutical sciences, 12, 1–14.
   PubMed Web of Science ®Google Scholar
• Samuels, B.L. and Bitran, J.D., 1995. High-dose intravenous melphalan: a review. Journal of clinical oncology, 13 (7), 1786–1799.
   PubMed Web of Science ®Google Scholar
• Sarosy, G., et al., 1988. The systemic administration of intravenous melphalan. Journal of clinical oncology, 6 (11), 1768–1782.
   PubMed Web of Science ®Google Scholar
• Shakeri-Zadeh, A., et al., 2009. Gold nanoparticles conjugated with folic acid using mercaptohexanol as the linker. International journal of nanotechnology, 1, 1–44.
   Google Scholar
• Shakeri-Zadeh, A., Ghasemifard, A.M., and Mansoori, G.A., 2010. Structural and optical characterization of folate-conjugated gold-nanoparticles. Physica E: low-dimensional systems and nanostructures, 42 (5), 1272–1280.
   Google Scholar
• Shakeri-Zadeh, A. and Mansoori, G.A., 2010. Cancer nanotechnology treatment through folate conjugated gold,nanoparticles. Proceedings of WCC 2010. (The 2nd World Congress on Cancer).
   Google Scholar
• Tiet, P. and Berlin, J.M., 2017. Exploiting homing abilities of cell carriers: targeted delivery of nanoparticles for cancer therapy. Biochemical pharmacology, 145, 18–26.
   PubMed Web of Science ®Google Scholar
• Tiwari, A., et al., 2007. Bone metastasis from ovarian cancer. Journal of cancer research and therapeutics, 3, 34–36.
   PubMedGoogle Scholar
• Wang, Y., et al., 2014. Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano letters, 14 (10), 5577–5583.
   PubMedGoogle Scholar
• Win, K.Y. and Feng, S.S., 2005. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26, 2713–2722.
   PubMed Web of Science ®Google Scholar
• Xu, L., et al., 2017. Folate-mediated chemotherapy and diagnostics: an updated review and outlook. Journal of controlled release, 252, 73–82.
   PubMed Web of Science ®Google Scholar
• Yuan, X., et al., 2017. Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles. International journal of nanomedicine, 12, 4981–4989.
   PubMed Web of Science ®Google Scholar
• Zadeh, A.S., et al., 2010. Cancerous cells targeting and destruction using folate conjugated gold nanoparticles. Dynamic biochemistry, process biotechnology and molecular biology, 4, 6–12.
   Google Scholar
• Zhang, T., et al., 2015. Self-assembled nanoparticles of amphiphilic twin drug from floxuridine and bendamustine for cancer therapy. Molecular pharmaceutics, 12 (7), 2328–2323.
   PubMedGoogle Scholar
• Zhang, X., Jackson, J.K., and Burt, H.M., 1996. Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique. Journal of biochemical and biophysical methods, 31 (3–4), 145–150.
   PubMedGoogle Scholar
• Zwicke, G.L., Mansoori, G.A., and Jeffery, C.J., 2012. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano reviews, 2012, 3.
   Google Scholar